Advantages and disadvantages of Yunnan Baiyao as an enterprise.

1. Advantages: confidential formula, monopoly. Disadvantages: The enterprise's R&D ability is extremely poor, and it has no development potential, so it belongs to a conservative enterprise.

2. Introduction of Yunnan Baiyao Group: Yunnan Baiyao was founded by Mr. Qu, a famous Yunnan folk doctor, in 1902. In 197 1 year, Yunnan Baiyao Factory, the predecessor of the company, was formally established and specialized production of Baiyao began. The company was listed on Shenzhen Stock Exchange on 1993, becoming the first A-share listed company in Yunnan Province. 1996 10 company changed its name to Yunnan Baiyao group co., ltd. after more than 30 years of development, the company has grown from a production enterprise with assets less than 3 million yuan to total assets of more than 7.63 billion yuan, and the total sales revenue has exceeded 65.438+0 billion yuan (at the end of 2065.438+00). Its business involves the research, production and sales of chemical raw materials, chemical preparations, Chinese patent medicines, Chinese herbal medicines, biological products, health foods, cosmetics and beverages. Wholesale, retail, purchase and sale of sugar, tea, building materials and decorative materials; It is a large-scale pharmaceutical enterprise group with the strongest strength and the best brand in the fields of science and technology, economic and technical consulting services, medical devices (Class II, medical dressings and disposable medical health products) and daily chemical products in Yunnan Province. The company's products are mainly Yunnan Baiyao series and Tianqi series, with more than 70 products in ten dosage forms, which are mainly sold to China, Hong Kong, Macao and Taiwan, Southeast Asia and other regions, and have entered the Japanese, European and American markets. "Yunnan Baiyao" trademark was awarded as a well-known trademark in China by the Trademark Office of the State Administration for Industry and Commerce in February 2002.

1, SWOT analysis of Yunnan Baiyao Group. Listed companies have abundant funds, good financial conditions and no financial crisis. In 20 10, Yunnan Baiyao realized its main business income 100. 7.5 billion yuan, 7 1 in 2009. 7.5 billion yuan, a net increase of 2.6 billion yuan, a year-on-year increase of 40. 4%, achieving a net profit of 9. 2.6 billion yuan, compared with 6.5 billion yuan in 2009. 400 million yuan, a year-on-year increase of 53. 3%; Rich natural medicine resources and profound national traditional medicine accumulation. Yunnan enjoys the reputation of "hometown of medicinal materials" because of its unique geographical and three-dimensional climatic conditions. In the struggle against various diseases, 26 ethnic groups in Yunnan Province have accumulated rich valuable experience in preventing and treating diseases and formed medical theories with national characteristics, among which Dai, Tibetan, Yi and other medicines are recorded. These are the solid foundations for developing the national medicine economy with natural medicines as the mainstay.

2. Advantages of Intellectual Property As a leader in the industry, Yunnan Baiyao has formed an all-round three-dimensional intellectual property protection system with patent rights and commercial technology secrets as the core and trademark rights (brands) and copyrights as the periphery. The formation of intellectual property protection system has laid a solid foundation for the company to explore the market and maximize its benefits. In addition, it has a prescription of state secrets and is monopolistic. Diversified development company actively expands its business in the fields of health and daily consumer goods on the basis of maintaining the leading position of traditional Chinese medicine. At present, the daily chemical products represented by Baiyao toothpaste have achieved good results, and the sales income has reached 10 billion yuan in 20 10. Lack of popularity and competitiveness. Although Yunnan Baiyao Group's products are sold to other parts of the mainland, Hong Kong, Macao and Taiwan, Southeast Asia and other regions, and have entered Japan, Europe and the United States and other countries, most of them are mixed with other brands' products in large pharmacies. Therefore, it seems a bit pale in expanding product popularity and competitiveness, and the product series is relatively single, relying too much on Yunnan Baiyao products.